Sep 8 2010
Medco Health Solutions, Inc. (NYSE: MHS) announced today that it has agreed to sell $500 million aggregate principal amount of 2.750% senior notes due September 15, 2015 and $500 million aggregate principal amount of 4.125% senior notes due September 15, 2020 in an underwritten public offering. Deutsche Bank Securities Inc. and Goldman, Sachs & Co. are acting as representatives of the several underwriters.
Medco intends to use the net proceeds from the offering for general corporate purposes, including repayment of borrowings under its senior unsecured revolving credit facility, which may include borrowings used to fund its previously announced acquisition of United BioSource Corporation. The offering is expected to close on September 10, 2010. The prospectus supplement and accompanying prospectus related to the offering of the notes may be obtained by contacting:
Source:
Medco Health Solutions, Inc.